Monitoring the Cascade of Tumor-specific Immune Response in vivo via Chemoenzymatic Proximity Labeling

被引:3
|
作者
Liang, Chao [1 ]
He, Jiaqi [1 ]
Zhao, Xin [4 ]
Hong, Jie [1 ]
Ma, Xianbin [3 ]
Mao, Mingchuan [1 ]
Nie, Weidong [1 ]
Wu, Guanghao [1 ]
Dong, Yuping [4 ]
Xu, Wei [1 ]
Huang, Lili [3 ]
Xie, Hai-Yan [2 ]
机构
[1] Beijing Inst Technol, Sch Life Sci, Beijing 100081, Peoples R China
[2] Peking Univ, Chem Biol Ctr, Sch Pharmaceut Sci, State Key Lab Nat & Biomimet Drugs, Beijing 100191, Peoples R China
[3] Beijing Inst Technol, Sch Med Technol, Beijing 100081, Peoples R China
[4] Beijing Inst Technol, Sch Mat Sci & Engn, Beijing 100081, Peoples R China
基金
中国国家自然科学基金;
关键词
Antitumor Immunity; Bioorthogonal Labelling; Chemoenzymatic Proximity-Labelling; Fucosyltransferase; Intercellular Interaction; T-CELL-ACTIVATION; DENDRITIC CELLS; DYNAMICS; LESSONS; CD4(+);
D O I
10.1002/anie.202304838
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Monitoring the highly dynamic and complex immune response remains a great challenge owing to the lack of reliable and specific approaches. Here, we develop a strategy to monitor the cascade of tumor immune response through the cooperation of pore-forming alginate gel with chemoenzymatic proximity-labeling. A macroporous gel containing tumor-associated antigens, adjuvants, and pro-inflammatory cytokines is utilized to recruit endogenous DCs and enhance their maturation in vivo. The mature DCs are then modified with GDP-fucose-fucosyltransferase (GDP-Fuc-Fuct) via the self-catalysis of fucosyltransferase (Fuct). Following the migration of the obtained Fuct-DCs to the draining lymph nodes (dLNs), the molecular recognition mediated interaction of DCs and T cells leads to the successful decoration of T cells with GDP-Fuc-azide through the Fuct catalyzed proximity-labeling. Therefore, the activated tumor-specific T cells in dLNs and tumors can be identified through bioorthogonal labeling, opening up a new avenue for studying the immune mechanism of tumors in situ. The cascade of cellular immune response, including the recruitment and mature of dendritic cell (DC), the activation of T cells in the draining lymph nodes and their transfer to the tumors, is monitored in vivo by integrating the pore-forming alginate gel promoted DC concentration and maturation with chemoenzymatic proximity-labeling.image
引用
收藏
页数:6
相关论文
共 50 条
  • [1] Tumor gangliosides inhibit the tumor-specific immune response
    McKallip, R
    Li, RX
    Ladisch, S
    [J]. JOURNAL OF IMMUNOLOGY, 1999, 163 (07): : 3718 - 3726
  • [2] Tumor-specific immune response: Current in vitro analyses may not reflect the in vivo immune status
    Faure, F
    Even, J
    Kourilsky, P
    [J]. CRITICAL REVIEWS IN IMMUNOLOGY, 1998, 18 (1-2) : 77 - 86
  • [3] Necrotic tumor cell death in vivo impairs tumor-specific immune responses
    Gamrekelashvili, Jaba
    Krueger, Christine
    von Wasielewski, Reinhard
    Hoffmann, Matthias
    Huster, Katharina M.
    Busch, Dirk H.
    Manns, Michael P.
    Korangy, Firouzeh
    Greten, Tim F.
    [J]. JOURNAL OF IMMUNOLOGY, 2007, 178 (03): : 1573 - 1580
  • [4] Tumor-specific immune responses
    Schreiber, Hans
    [J]. SEMINARS IN IMMUNOLOGY, 2008, 20 (05) : 265 - 266
  • [5] TUMOR-SPECIFIC IMMUNE MECHANISMS
    SMITH, RT
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1968, 278 (23): : 1268 - &
  • [6] TUMOR-SPECIFIC IMMUNE MECHANISMS
    SMITH, RT
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1968, 278 (22): : 1207 - &
  • [7] POTENTIATION OF TUMOR-SPECIFIC IMMUNE-RESPONSE BY CORYNEBACTERIUM PARVUM
    SCOTT, MT
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1975, 55 (01) : 65 - 72
  • [8] Tumor-specific circRNAs elicit anti-tumor immune response via encoding cryptic antigenic peptides
    Huang, Di
    Chen, Jianing
    Su, Shicheng
    Song, Erwei
    [J]. CANCER RESEARCH, 2024, 84 (09)
  • [9] Human Tumor Cells Killed by Anthracyclines Induce a Tumor-Specific Immune Response
    Fucikova, Jitka
    Kralikova, Petra
    Fialova, Anna
    Brtnicky, Tomas
    Rob, Lukas
    Bartunkova, Jirina
    Spisek, Radek
    [J]. CANCER RESEARCH, 2011, 71 (14) : 4821 - 4833
  • [10] In vivo selection of tumor-specific antibodies
    Sanchez-Martin, David
    Sanz, Laura
    Ruoslahti, Erkki
    Alvarez-Vallina, Luis
    [J]. ONCOTARGET, 2013, 4 (10) : 1547 - 1547